Publication | Closed Access
Empagliflozin as Add On to Basal Insulin for 78 Weeks Improves Glycemic Control with Weight Loss in Insulin-Treated Type 2 Diabetes (T2DM)
38
Citations
0
References
2013
Year
ObesityMetabolic SyndromeDiabetes ManagementWeight LossBasal InsulinMedicineInsulin ManagementPhysiologyDiabetesInsulin-treated Type 2Diabetes MellitusEndocrinologyPharmacologyHealth Sciences
No additional data available for this publication yet. Check back later!